Amylin Pharmaceuticals downgraded to "market perform" |...
Amylin Pharmaceuticals downgraded to "market perform", Wachovia Securities...
Amylin Pharmaceuticals to Webcast Annual Meeting of Stockholders...
ForRelease.com ... the archive. Find more about: OLDER NEWER. Amylin Pharmaceuticals to Webcast Annual Meeting of Stockholders Presentation...
Amylin Pharmaceuticals to Webcast Update on SYMLIN(R) Regulatory...
ForRelease.com ... the archive. Find more about: OLDER NEWER. Amylin Pharmaceuticals to Webcast Update on SYMLIN(R) Regulatory Status. SAN DIEGO,...
Amylin Pharmaceuticals, Inc.
Pipeline | Research | Investors | News & Events | Careers Site Map | Terms of Use | Updates | PRIVACY © 2005 Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. - Fact Sheet - Hoover's Online
Amylin Pharmaceuticals may help diabetics gain the upper hand in their battle with the disease. The company develops therapies to treat diabetes and...
Amylin Pharmaceuticals, Inc. - Current Career Opportunities
Summary Yes No. Copyright © 2003 Amylin Pharmaceuticals, Inc. an AA/EEO employer, All rights reserved. Additional legal information...
Amylin Pharmaceuticals Corporate Profile
Amylin Pharmaceuticals, Inc. is a development pharmaceutical company focused on metabolic disorders with a concentration in diabetes.
NetSci: The Biotech YellowPages - Amylin Pharmaceuticals, Inc.
The NetSci Pharmaceutical and Biotech YellowPages - Amylin Pharmaceuticals, Inc.
Amylin Product Pipeline - AC2993
The FDA's action date for exenatide is April 30, 2005. Copyright © 2003 Amylin Pharmaceuticals, Inc. All rights reserved.
Amylin Pharmaceuticals: Diabetes Relief - Forbes.com
Stock Of The Week Amylin Pharmaceuticals: Diabetes Relief John Dobosz, 05.13.04, 9:00 AM ET...
NOTE: Please contact us right away if you'd like to make any changes to your listing.
Powered by Search Enhancement © 2005
Home | Index
|
|